127 related articles for article (PubMed ID: 8363255)
1. Antiviral activity of a synthetic double-stranded polyribonucleotide interferon inducer in a murine AIDS retrovirus model. Role of augmentation of natural killer cell activity and synergy with oral AZT.
Black PL; McKinnon KM; Wooden SL; Ussery MA
Ann N Y Acad Sci; 1993 Jun; 685():467-70. PubMed ID: 8363255
[No Abstract] [Full Text] [Related]
2. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
Black PL; McKinnon KM; Wooden SL; Ussery MA
Int J Immunopharmacol; 1996 Nov; 18(11):633-50. PubMed ID: 9089007
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA
Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of virus-induced murine diabetes by an interferon inducer.
Gadzik JP; Naji A; Barker CF; Blank KJ
J Interferon Res; 1982; 2(1):59-63. PubMed ID: 6286804
[No Abstract] [Full Text] [Related]
5. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
[TBL] [Abstract][Full Text] [Related]
6. Activation of natural killer cells in newborn piglets by interferon induction.
Lesnick CE; Derbyshire JB
Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948
[TBL] [Abstract][Full Text] [Related]
7. Use of human monocytes in the evaluation of antiviral drugs: quantitation of HSV-1 cytopathic effects.
Lazdins J; Alteri E; Cook KW; Burgin C; Gangemi JD
Antiviral Res; 1990 Apr; 13(4):175-86. PubMed ID: 2166467
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of hematopoietic stem cells by interferon inducer in nonhuman primates receiving fractionated total body irradiation.
Lvovsky EA; Levine PH; Bengali Z; Leiseca SA; Cicmanec JL; Robinson JE; Bautro N; Levy HB; Scott RM
Int J Radiat Oncol Biol Phys; 1982 Oct; 8(10):1721-6. PubMed ID: 6759479
[No Abstract] [Full Text] [Related]
9. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Loewen KG; Derbyshire JB
Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation of natural killer activity by polyribonucleotides.
Wiltrout RH; Salup RR; Twilley TA; Talmadge JE
J Biol Response Mod; 1985 Oct; 4(5):512-7. PubMed ID: 4078596
[TBL] [Abstract][Full Text] [Related]
11. Biological characterization of MVE-2 and poly ICLC.
Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
[No Abstract] [Full Text] [Related]
12. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
Pessina GP; Muscettola M; Paulesu L; Bocci V
J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of natural killer cell activity by murine retroviral infection and cocaine.
Poet TS; Pillai R; Wood S; Watson RR
Toxicol Lett; 1991 Dec; 59(1-3):147-52. PubMed ID: 1755020
[TBL] [Abstract][Full Text] [Related]
14. Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.
Riley FL; Morin ML; Lvovsky E; Stephens EE; Levy HB
Proc Soc Exp Biol Med; 1982 Feb; 169(2):183-8. PubMed ID: 6174989
[No Abstract] [Full Text] [Related]
15. Interferons and interferon inducers in cancer treatment.
Krown SE
Semin Oncol; 1986 Jun; 13(2):207-17. PubMed ID: 2424089
[No Abstract] [Full Text] [Related]
16. Biological response modifier-mediated resistance to herpesvirus infections requires induction of alpha/beta interferon.
Kunder SC; Kelly KM; Morahan PS
Antiviral Res; 1993 Jun; 21(2):129-39. PubMed ID: 7687839
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
Zhang SR; Salup RR; Urias PE; Twilley TA; Talmadge JE; Herberman RB; Wiltrout RH
Cancer Immunol Immunother; 1986; 21(1):19-25. PubMed ID: 3484675
[TBL] [Abstract][Full Text] [Related]
18. The kinetics of interferon induction by poly ICLC in humans.
Bever CT; McFarland HF; McFarlin DE; Levy HB
J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
[TBL] [Abstract][Full Text] [Related]
20. Tumor response to interferon inducer and radiation effect of serum interferon levels.
Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
